References
- Pichler P, Jaccard I, Weisz U, et al. International comparison of health care carbon footprints. Environ Res Lett. 2019;14:064004.
- Eckelman MJ, Sherman JD, MacNeill AJ. Life cycle environmental emissions and health damages from the Canadian healthcare system: an economic-environmental-epidemiological analysis. PLoS Med. 2018;15:e1002623.
- Christel M. Pharm Exec top 50 companies. Pharm Exec. 2021;41:26–29.
Reference
- Heer J. Agency plus automation: designing artificial intelligence into interactive systems. Proc Natl Acad Sci U S A. 2019;116(6):1844–1850.
Reference
- Shin RK, Rammohan KW, Williams MJ. Expert perspectives on COVID-19 vaccination for people living with multiple sclerosis. Neurol Ther. 2021;10(2):415–425.
References
- Ruth A, Subramanian R, Suchy J, et al. Consumption of publication content—mapping the audience journey to inform omnichannel planning in an open world. Curr Med Res Opin. 2020;36(suppl 1):7–8.
- Fazzone W, Bessler J, Darby C, et al. Trends in the use of omnichannel approaches to transform publication planning: results of a cross-sectional survey of medical publications professionals. Curr Med Res Opin. 2021;37(suppl 1):18–19.
Reference
- Lewis M, Falsetti S, Hatfield R, et al. Is there a blueprint for biotech pre-launch peer-review publication planning? Original abstracts from the 2021 European Meeting of ISMPP. Curr Med Res Opin. 2021;37:(sup1):21–39.
References
- Patient Focused Medicine Development. Patient engagement quality guidance. 2018. [cited 2022 Jan 12]. Available from: https://patientfocusedmedicine.org/peqg/patient-engagement-quality-guidance.pdf.
- Woolley KL, Arnstein L, Hamoir AM et al. Development and use of 2 tools to facilitate and evaluate patient authorship. Poster presentation at the 15th Annual Meeting of the International Society for Medical Publication Professionals; 15–17 April 2019; National Harbor, MD, USA.
- Law N, Davio K, Blunck M, et al. The lived experience of myasthenia gravis: a patient-led analysis. Neurol Ther. 2021;10:1103–1125.
Reference
- Sabir S, Farrow P, Buys M, et al. Registration and use of ORCID by pharma. 2020 European Meeting of ISMPP; London, UK.
References
- European Medicines Agency (Clinical Trial Regulation No. 536/2014). Available from: https://ec.europa.eu/health/human-use/clinical-trials/regulation_en
- EU Guidance for writing clinical lay summaries. Available from: https://ec.europa.eu/health/sites/default/files/files/eudralex/vol-10/2017_01_26_summaries_of_ct_results_for_laypersons.pdf
- Draft FDA Guidance on provision of plain language summaries. Available from: https://mrctcenter.org/blog/resources/2017-09-06-guidance-document-draft-fda-guidance-provision-plain-language-summaries/
References
- Moseson H, Zazanis N, Goldberg E, et al. The imperative for transgender and gender nonbinary inclusion. Obstet Gynecol. 2020;135:1059–68.
- NIAID HIV Language Guide. The National Institute of Allergy and Infectious Diseases (NIAID). [cited 2022 Jan 14]. Available from: https://www.hptn.org/sites/default/files/inline-files/NIAID%20HIV%20Language%20Guide%20-%20March%202020.pdf.
- Gender. American Psychological Association. [cited 2022 Jan 14]. Available from: https://apastyle.apa.org/style-grammar-guidelines/bias-free-language/gender.
- Bartick M, Stehel EK, Calhoun SL, et al. Academy of Breastfeeding Medicine position statement and guidance: infant feeding and lactation-related language and gender. Breastfeed Med. 2021;16:587–890.
References
- Elwyn G, Durand MA, Song J, et al. A three-talk model for shared decision making: multistage consultation process. BMJ. 2017;359:j4891.
- Beach MC, Sugarman J. Realizing Shared Decision-making in Practice. JAMA. 2019;322(9):811–812.
- Arnstein L, Lobban D, Ebina H, et al. Compliance-related questions and comments about plain language summaries of publications: a thematic analysis. Curr Med Res Opin. 2020;36:(sup1):7.
References
- Gaba JF, Siebert M, Dupuy A, et al. Funders’ data-sharing policies in therapeutic research: a survey of commercial and non-commercial funders. PLoS One. 2020;15:e0237464.
- Hrynaszkiewicz I, Cadwallader L. Dataset from: a survey of funders’ and institutions’ needs for understanding researchers’ open research practices. 2021. Available from: https://doi.org/https://doi.org/10.6084/m9.figshare.14994498.v1
Reference
- Wolf F, Shah S, Meier C, et al. What doctors want and what this means for biopharma now. Boston Consulting Group; 2020. Available from: https://www.bcg.com/en-il/publications/2020/what-doctorswant-and-what-this-means-for-the-biopharma-industry
Reference
- Patel J, Halford C, Shepherd A. Article enhancements: a beginners guide. [cited 2022 Jan 17]. Available from: https://ismpp.memberclicks.net/social-media-and-web-metrics-resources?servId=10046?servId=10046&servId=10046?servId=10046&servId=10046?servId=10046&servId=10046.
References
- Tsujimoto Y, Aoki T, Shinohara K, et al. Physician characteristics associated with proper assessment of overstated conclusions in research abstracts: a secondary analysis of a randomized controlled trial. PLoS One. 2019;14:e0211206.
- Shinohara K, Suganuma AM, Imai H, et al. Overstatements in abstract conclusions claiming effectiveness of interventions in psychiatry: a meta-epidemiological investigation. PLoS One. 2017;12:e0184786.
- Hyland K, Feng J. ‘Our striking results demonstrate…’: persuasion and the growth of academic hype. J Pragmat. 2021;182:189–202.
- Millar N, Budgell B, Salager-Meyerc F, et al. Hype in reports of clinical research: the authors’ perspectives. English Specif Purp. 2020;60:53–64.
- Lerchenmueller MJ, Sorenson O, Frank F, et al. Gender differences in how scientists present the importance of their research: observational study. BMJ. 2019;367:I6573.